CASTAGNA, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 5.085
EU - Europa 3.490
AS - Asia 2.702
SA - Sud America 402
AF - Africa 47
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.741
Nazione #
US - Stati Uniti d'America 5.029
CN - Cina 1.021
GB - Regno Unito 1.012
SG - Singapore 991
DE - Germania 468
BR - Brasile 349
SE - Svezia 347
IT - Italia 333
HK - Hong Kong 305
RU - Federazione Russa 289
FR - Francia 284
IE - Irlanda 259
FI - Finlandia 243
KR - Corea 77
JP - Giappone 75
VN - Vietnam 75
UA - Ucraina 69
BE - Belgio 45
NL - Olanda 34
IN - India 30
TR - Turchia 29
CA - Canada 28
ID - Indonesia 20
AR - Argentina 15
MX - Messico 15
PL - Polonia 15
BD - Bangladesh 12
AT - Austria 11
ES - Italia 11
VE - Venezuela 11
ZA - Sudafrica 11
AU - Australia 10
CL - Cile 10
LT - Lituania 9
RO - Romania 9
CH - Svizzera 8
IR - Iran 8
UZ - Uzbekistan 8
IQ - Iraq 7
EG - Egitto 6
IL - Israele 6
SA - Arabia Saudita 6
TG - Togo 6
DZ - Algeria 5
EC - Ecuador 5
GR - Grecia 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
EE - Estonia 4
KE - Kenya 4
KG - Kirghizistan 4
PK - Pakistan 4
PT - Portogallo 4
BH - Bahrain 3
BO - Bolivia 3
CO - Colombia 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
LV - Lettonia 3
MA - Marocco 3
PE - Perù 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
DK - Danimarca 2
ET - Etiopia 2
NO - Norvegia 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
MW - Malawi 1
Totale 11.731
Città #
Southend 856
Chandler 741
Dallas 735
Jacksonville 506
Singapore 478
Ann Arbor 359
Woodbridge 307
Hong Kong 299
Ashburn 271
Dublin 259
Houston 203
Beijing 169
New York 146
Verona 130
Wilmington 119
Munich 113
Lawrence 102
Princeton 102
Jinan 84
Nanjing 77
Boardman 76
Tokyo 73
Shenyang 70
Helsinki 65
The Dalles 63
Los Angeles 54
Brussels 45
Hebei 42
Columbus 41
Turku 38
Redmond 35
Sindelfingen 34
Lancaster 33
Santa Clara 32
Zhengzhou 31
Changsha 30
São Paulo 30
Tianjin 30
Haikou 29
Nanchang 29
Milan 27
Jiaxing 25
Buffalo 24
Redondo Beach 24
Seattle 24
Hangzhou 22
Dong Ket 20
Taiyuan 20
Guangzhou 19
Padova 19
Ningbo 17
Seoul 17
Taizhou 17
Jakarta 16
Rio de Janeiro 16
Falls Church 15
Ho Chi Minh City 15
Norwalk 15
Nürnberg 14
Brooklyn 13
Fuzhou 13
San Francisco 13
Fairfield 12
Toronto 12
Washington 12
Boydton 11
Council Bluffs 11
Dearborn 11
London 11
Redwood City 11
Chicago 10
Warsaw 10
Bexley 9
Bologna 9
Düsseldorf 9
Frankfurt am Main 9
Hanoi 9
Lanzhou 9
Nuremberg 9
Phoenix 9
Stockholm 9
Vienna 9
Johannesburg 8
Zurich 8
Amsterdam 7
Belo Horizonte 7
San Mateo 7
Shanghai 7
Tashkent 7
Ankara 6
Auburn Hills 6
Boston 6
Lomé 6
Mexico City 6
Moscow 6
Trento 6
Ardabil 5
Baghdad 5
Charlotte 5
Clearwater 5
Totale 7.655
Nome #
Epigenetic Regulation Through Histone Deacetylation: Implications and Therapeutic Potential in Hepatocellular Carcinoma 277
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 262
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 154
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 148
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 146
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 144
The proteome: anno Domini 2002 143
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 141
Identification of new BMP6 pro-peptide mutations in patients with iron overload 137
Immunoaffinity reactors for prion protein qualitative analysis 135
miRNAs purification and analysis from urinary exosomes. 134
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 134
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 132
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 132
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 132
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 128
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 127
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 127
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 126
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 126
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 125
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 124
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 124
“Proteomics approaches for studying chemoresistance in cancer” 123
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 123
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 122
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 122
"Exploring the hidden human urinary proteome via ligand library beads" 121
Altered paraoxonase expression in patients with genetic haemochromatosis. 120
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 120
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 119
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 119
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 117
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 116
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 116
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 116
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 115
Murine macrophages response to iron 113
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 112
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 112
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 112
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 111
Monocyte/macrophage proteomics: recent findings and biomedical applications. 110
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 110
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 109
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 109
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 109
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 108
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 108
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 107
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 106
"Prefractionation of urinary proteins" 105
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 104
Iron metabolism in Murine Macrophages: a proteomic insight. 104
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 103
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 101
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 101
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 101
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 99
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 98
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 98
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 98
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 97
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 97
Reduced serum hepcidin levels in patients with chronic hepatitis C 96
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 95
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 94
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 94
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 94
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 93
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 93
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 93
Beta-elimination: an unexpected artefact in proteome analysis. 92
Optimizing the purification and analysis of miRNAs from urinary exosomes. 91
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 90
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 90
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 87
Prefractionation techniques in proteome analysis. 86
Prefractionation techniques in proteome analysis. 85
Reducing protein concentration range of biological samples using solid-phase ligand libraries 84
Hormone-Dependent Changes in Female Urinary Proteome 84
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 84
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 84
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 83
Modern iron replacement therapy: clinical and pathophysiological insights 82
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 82
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 81
”SPR biosensors and “natural hepcidin receptor” immobilization for hepcidin-25 determination in serum.” 81
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 80
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 80
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 80
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 79
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 77
Hepcidin resistance in dysmetabolic iron overload 76
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 75
Recent trends in proteome analysis. 72
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 71
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 68
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin 66
Treatment options for anemia in the elderly 65
Totale 10.876
Categoria #
all - tutte 45.469
article - articoli 35.168
book - libri 0
conference - conferenze 9.214
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.087
Totale 90.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021656 0 0 64 107 109 89 25 53 45 25 91 48
2021/2022812 62 256 8 63 25 25 7 37 43 18 75 193
2022/20232.027 120 231 167 335 199 474 31 127 261 12 36 34
2023/20241.075 43 88 72 106 117 209 21 69 12 29 189 120
2024/20252.503 125 183 123 427 97 94 128 86 344 160 209 527
2025/20261.718 562 407 749 0 0 0 0 0 0 0 0 0
Totale 11.896